Susan G Dorsey

University Of Maryland Baltimore

$16,761,780

Attributed

$28,279,748

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.5M · FY2005–23

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$36,917,164 · 18

By mechanism

R01$20,031,836 · 6

P30$13,448,807 · 7

RC2$2,204,914 · 1

R21$916,729 · 2

K22$295,818 · 1

F31$19,060 · 1

Top collaborators

Most similar at University Of Maryland Baltimore

Same institution · by research overlap

Richard J Traub$7,380,364
Jin Y Ro$11,441,623
Mari Griffioen$869,653
Ke Ren$10,649,004
Junfang Wu$12,285,191

Others in their field

Top investigators on “Pain”

Emer Leahy · Psychogenics, Inc.$49,781,254
Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
J Richard Landis · University Of Pennsylvania$34,799,488
Clifford J Woolf · Boston Children'S Hospital$30,992,766
Emeran A Mayer · University Of California Los Angeles$29,229,798
Pamela Susan Douglas · Duke University$28,862,172

Research focus

PainReportingChronic PainPhenotypeChronicGeneticAffectCostGenesPain ManagementMediatingSymptomsBasePilot ProjectsNociceptionPathway InteractionsQuality Of LifeResponseAmericanProductivityMedicineAmericasEpidemicDorsal Horn

Grant awards (83)

Secondary Analysis and Integration of Existing Data Related to Chronic Orofacial Pain and Placebo Effects - Administrative Supplement$87,840

R21 · FY2023 · DE

Neurophysiological and transcriptomic predictors of chronic low back pain: towards precision pain management (NEAT Study)$618,963

R01 · FY2022 · NR · contact PI

Physiological, psychological, and genomic factors that predict the transition from acute to chronic pain in patients with traumatic lower extremity fracture$610,764

R01 · FY2022 · NR

Secondary Analysis and Integration of Existing Data Related to Chronic Orofacial Pain and Placebo Effects$424,875

R21 · FY2022 · DE

Neurophysiological and transcriptomic predictors of chronic low back pain: towards precision pain management (NEAT Study)$620,173

R01 · FY2021 · NR · contact PI

Physiological, psychological, and genomic factors that predict the transition from acute to chronic pain in patients with traumatic lower extremity fracture$610,827

R01 · FY2021 · NR

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy$542,043

R01 · FY2021 · NR · contact PI

Neurophysiological and transcriptomic predictors of chronic low back pain: towards precision pain management (NEAT Study)$619,073

R01 · FY2020 · NR · contact PI

Physiological, psychological, and genomic factors that predict the transition from acute to chronic pain in patients with traumatic lower extremity fracture$611,314

R01 · FY2020 · NR

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy$552,765

R01 · FY2020 · NR · contact PI

Omics Associated with Self-management Interventions for Symptoms (OASIS) Center$539,456

P30 · FY2020 · NR · contact PI

Administrative Core$123,782

P30 · FY2020 · NR · contact PI

Neurophysiological and transcriptomic predictors of chronic low back pain: towards precision pain management (NEAT Study)$638,021

R01 · FY2019 · NR · contact PI

Physiological, psychological, and genomic factors that predict the transition from acute to chronic pain in patients with traumatic lower extremity fracture$620,913

R01 · FY2019 · NR

Mechanisms Underlying Comorbid Pain Conditions in a Clinically Relevant Model$573,986

R01 · FY2019 · NR

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy$563,718

R01 · FY2019 · NR · contact PI

Omics Associated with Self-management Interventions for Symptoms (OASIS) Center$525,232

P30 · FY2019 · NR · contact PI

Administrative Core$120,518

P30 · FY2019 · NR · contact PI

Physiological, psychological, and genomic factors that predict the transition from acute to chronic pain in patients with traumatic lower extremity fracture$619,993

R01 · FY2018 · NR

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy$574,455

R01 · FY2018 · NR · contact PI

Omics Associated with Self-management Interventions for Symptoms (OASIS) Center$540,703

P30 · FY2018 · NR · contact PI

Mechanisms Underlying Comorbid Pain Conditions in a Clinically Relevant Model$496,849

R01 · FY2018 · NR

Administrative Core$124,067

P30 · FY2018 · NR · contact PI

Mechanisms Underlying Comorbid Pain Conditions in a Clinically Relevant Model$671,540

R01 · FY2017 · NR

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy$585,613

R01 · FY2017 · NR · contact PI

Omics Associated with Self-management Interventions for Symptoms (OASIS) Center$540,606

P30 · FY2017 · NR · contact PI

Administrative Core$122,815

P30 · FY2017 · NR · contact PI

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy$573,014

R01 · FY2016 · NR · contact PI

Mechanisms Underlying Comorbid Pain Conditions in a Clinically Relevant Model$568,201

R01 · FY2016 · NR

Omics Associated with Self-management Interventions for Symptoms (OASIS) Center$539,000

P30 · FY2016 · NR · contact PI

Center for the Genomics of Pain$478,308

P30 · FY2016 · NR · contact PI

Administrative Core$384,378

P30 · FY2016 · NR · contact PI

Administrative Core$123,677

P30 · FY2016 · NR · contact PI

Mechanisms Underlying Comorbid Pain Conditions in a Clinically Relevant Model$62,720

R01 · FY2016 · NR

Mechanisms Underlying Comorbid Pain Conditions in a Clinically Relevant Model$578,401

R01 · FY2015 · NR

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy$555,825

R01 · FY2015 · NR · contact PI

Center for the Genomics of Pain$463,957

P30 · FY2015 · NR · contact PI

Administrative Core$372,846

P30 · FY2015 · NR · contact PI

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy$670,470

R01 · FY2014 · NR · contact PI

Epigenetic Modifications of BDNF and trkB Genes Underlie Pain Plasticity$561,276

R01 · FY2014 · NR · contact PI

Center for the Genomics of Pain$473,524

P30 · FY2014 · NR · contact PI

Administrative Core$382,785

P30 · FY2014 · NR · contact PI

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy$670,256

R01 · FY2013 · NR · contact PI

Epigenetic Modifications of BDNF and trkB Genes Underlie Pain Plasticity$600,065

R01 · FY2013 · NR · contact PI

Center for the Genomics of Pain$453,434

P30 · FY2013 · NR · contact PI

UMB Center for Pain Studies$415,133

P30 · FY2013 · NR · contact PI

Administrative Core$401,295

P30 · FY2013 · NR · contact PI

Administrative Core$364,390

P30 · FY2013 · NR · contact PI

Biostatiscs Core$14,698

P30 · FY2013 · NR · contact PI

Spinal Mechanisms Underlying SCI-Induced Pain: Implications for Targeted Therapy$716,800

R01 · FY2012 · NR · contact PI

Epigenetic Modifications of BDNF and trkB Genes Underlie Pain Plasticity$652,565

R01 · FY2012 · NR · contact PI

Center for the Genomics of Pain$478,309

P30 · FY2012 · NR · contact PI

UMB Center for Pain Studies$461,199

P30 · FY2012 · NR · contact PI

Administrative Core$445,532

P30 · FY2012 · NR · contact PI

Administrative Core$384,379

P30 · FY2012 · NR · contact PI

Biostatiscs Core$15,827

P30 · FY2012 · NR · contact PI

Epigenetic Modifications of BDNF and trkB Genes Underlie Pain Plasticity$672,810

R01 · FY2011 · NR · contact PI

UMB Center for Pain Studies$475,201

P30 · FY2011 · NR · contact PI

Administrative Core$446,751

P30 · FY2011 · NR · contact PI

BDNF Signal Strength Modulates NRTI-Induced Allodynia in the Mouse$356,949

R01 · FY2011 · NR · contact PI

Biostatiscs Core$28,450

P30 · FY2011 · NR · contact PI

UMB Center for Pain Studies$1,298,153

P30 · FY2010 · NR · contact PI

TrkB.T1 as a Genetic Disease Modifier of Muscular Dystrophy$1,096,812

RC2 · FY2010 · NR · contact PI

Epigenetic Modifications of BDNF and trkB Genes Underlie Pain Plasticity$712,271

R01 · FY2010 · NR · contact PI

UMB Center for Pain Studies$475,201

P30 · FY2010 · NR · contact PI

Administrative Core$447,212

P30 · FY2010 · NR · contact PI

BDNF Signal Strength Modulates NRTI-Induced Allodynia in the Mouse$360,555

R01 · FY2010 · NR · contact PI

BDNF Signal Strength Modulates NRTI-Induced Allodynia in the Mouse$99,613

R01 · FY2010 · NR · contact PI

Biostatiscs Core$27,989

P30 · FY2010 · NR · contact PI

TrkB.T1 as a Genetic Disease Modifier of Muscular Dystrophy$1,108,102

RC2 · FY2009 · NR · contact PI

BDNF Signal Strength Modulates NRTI-Induced Allodynia in the Mouse$506,656

R01 · FY2009 · NR · contact PI

UMB Center for Pain Studies$480,000

P30 · FY2009 · NR · contact PI

Administrative Core$452,181

P30 · FY2009 · NR · contact PI

BDNF Signal Strength Modulates NRTI-Induced Allodynia in the Mouse$99,262

R01 · FY2009 · NR · contact PI

Biostatiscs Core$27,819

P30 · FY2009 · NR · contact PI

BDNF Signal Strength Modulates NRTI-Induced Allodynia in the Mouse$364,196

R01 · FY2008 · NR · contact PI

BDNF Signal Strength Modulates NRTI-Induced Allodynia in the Mouse$147,671

R01 · FY2008 · NR · contact PI

BDNF Signal Strength Modulates NRTI-Induced Allodynia in the Mouse$371,250

R01 · FY2007 · NR · contact PI

Supraspinal BDNF Signaling Modulates Nociception$181,264

R21 · FY2006 · NR · contact PI

TRUNCATED TRKB DURING DEVELOPMENT AND IN NEURON SURVIVAL$148,429

K22 · FY2006 · NR · contact PI

Supraspinal BDNF Signaling Modulates Nociception$222,750

R21 · FY2005 · NR

TRUNCATED TRKB DURING DEVELOPMENT AND IN NEURON SURVIVAL$147,389

K22 · FY2005 · NR

CLINICAL OUTCOMES ASSESSMENT METHODOLOGY$19,060

F31 · FY2000 · NR